Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virax Biolabs has developed a portfolio of diagnostic products focused on measuring T cell responses to viral infections. Their lead platform—ViraxImmune™—enables detailed immunological profiling using advanced ELISpot/FluoroSpot technology. The company’s tests are being clinically validated for use in diagnosing post-infectious syndromes like Long COVID and supporting vaccine efficacy monitoring. No therapeutic drugs are under development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virax Biolabs.